In part 2 of our discussion on Alzheimer's diagnostics, our host, Jane Caldwell, speaks with Dr. Francesca De Simone. Dr. De Simone is Scientific Affairs Manager for Fujirebio Diagnostics and leads the company's neurodegenerative disease program. Dr. De Simone discusses the role of blood-based biomarkers for Alzheimer's disease in comparison to other forms of diagnostic tests, as well as her insights on the clinical needs for Alzheimer's and current progress in the field. Educational su...
All content for On Medical Grounds is the property of Medavera and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In part 2 of our discussion on Alzheimer's diagnostics, our host, Jane Caldwell, speaks with Dr. Francesca De Simone. Dr. De Simone is Scientific Affairs Manager for Fujirebio Diagnostics and leads the company's neurodegenerative disease program. Dr. De Simone discusses the role of blood-based biomarkers for Alzheimer's disease in comparison to other forms of diagnostic tests, as well as her insights on the clinical needs for Alzheimer's and current progress in the field. Educational su...
Dr. Douglas Galasko - Alzheimer’s disease: Simple blood test, diagnostic clarity (Part 1)
On Medical Grounds
43 minutes
1 month ago
Dr. Douglas Galasko - Alzheimer’s disease: Simple blood test, diagnostic clarity (Part 1)
Join our host Jane Caldwell for a discussion with Dr. Douglas Galasko, the Associate Director of the UC San Diego Shiley Marcos Alzheimer's Disease Research Center. Dr. Galasko will discuss the recently approved pTau217/β-Amyloid 1-42 plasma ratio test, the first blood biomarker test for Alzheimer's disease. He will talk about the role of this and other diagnostic tools, and what an early diagnosis can mean for patients and their families. Educational support provided by Fujirebio Diagnostics...
On Medical Grounds
In part 2 of our discussion on Alzheimer's diagnostics, our host, Jane Caldwell, speaks with Dr. Francesca De Simone. Dr. De Simone is Scientific Affairs Manager for Fujirebio Diagnostics and leads the company's neurodegenerative disease program. Dr. De Simone discusses the role of blood-based biomarkers for Alzheimer's disease in comparison to other forms of diagnostic tests, as well as her insights on the clinical needs for Alzheimer's and current progress in the field. Educational su...
